The fast track status is for the development of evofosfamide (previously known as TH-302) in combination with gemcitabine to treat these patients. Evofosfamide is an investigational drug which
Patient enrolment is expected to be initiated shortly in this trial, which allows the company to combine its HS-110 with multiple immune modulating strategies. HS-110 is the company’s
With the acquisition, Juno will now have access to transformative cell selection and activation capabilities, advanced manufacturing automation, improved supply chain and lower expected cost of goods. According
Amitiza is a chloride channel activator that acts locally in the small intestine to restore motility and to address the underlying pathophysiology and secondary symptoms of constipation. Under
Under the deal, the parties will explore and test the value of digital health solutions, mobile technologies and insights from advanced data analytics in the delivery of health
The PMA application seeks approval for tumor treating fields (TTFields), in combination with temozolomide chemotherapy, as a first-line treatment for glioblastoma (GBM). The submission of PMA is based
Objective of the project is to use power of the body’s own immune system to attack cancer cells and discover possible new treatment options for cancer patients. By
An upfront payment of $87.5m has been made by Pfizer for the minority equity interest and exclusive option. As part of the deal, Pfizer will make additional potential
The agency has acknowledged receipt of the application and will notify the company when the review process is completed. If the FDA grants orphan drug designation, Trevyent would
The deal will focus on the development of basic research including studies on pathogenesis and drug susceptibility of cancer by promoting exchanges among researchers, physicians, and others engaged
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.